TNBI Stock Chart & Stats
$0.02
$0.00(0.00%)
At close: 4:00 PM EDT
$0.02
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.02 - $0.06
Previous CloseN/A
Volume5.00
Average Volume (3M)3.25K
Market Cap
$327.59K
Enterprise Value$552.94K
Total Cash (Recent Filing)$37.30K
Total Debt (Recent Filing)$140.00K
Price to Earnings (P/E)―
Beta3.24
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding24,537,615
10 Day Avg. Volume5,700
30 Day Avg. Volume3,250
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)-1.68
Price to Sales (P/S)79.44
P/FCF Ratio-18.11
Enterprise Value/Market Cap1.69
Enterprise Value/Revenue65.59
Enterprise Value/Gross Profit85.40
Enterprise Value/Ebitda-4.31
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
TNBI FAQ
What was Tanke Biosciences Corporation’s price range in the past 12 months?
Tanke Biosciences Corporation lowest stock price was $0.01 and its highest was $0.06 in the past 12 months.
What is Tanke Biosciences Corporation’s market cap?
Tanke Biosciences Corporation’s market cap is $327.59K.
When is Tanke Biosciences Corporation’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Tanke Biosciences Corporation’s earnings last quarter?
Currently, no data Available
Is Tanke Biosciences Corporation overvalued?
According to Wall Street analysts Tanke Biosciences Corporation’s price is currently Overvalued.
Does Tanke Biosciences Corporation pay dividends?
Tanke Biosciences Corporation does not currently pay dividends.
What is Tanke Biosciences Corporation’s EPS estimate?
Tanke Biosciences Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tanke Biosciences Corporation have?
Tanke Biosciences Corporation has 24,537,615 shares outstanding.
What happened to Tanke Biosciences Corporation’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Tanke Biosciences Corporation?
Currently, no hedge funds are holding shares in TNBI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Tanke Biosciences Corporation
Tanke Biosciences Corporation (TNBI) is a company dedicated to the development, production, and sale of a diverse portfolio of animal nutrition and feed additive products through its various subsidiaries. The company organizes its business into four distinct categories: organic trace mineral additives, functional regulation additives, herbal medicinal additives, and other related offerings. Among its product lineup, Tanke Biosciences provides organic trace mineral additives marketed under the Qili brand. It also produces Qilicid feed acidifiers, which are crucial for preventing microbial spoilage of raw ingredients and finished animal feeds. The company's offerings further include various seasonings and Tankeball branded flavor enhancers, designed to act as agents in the creation of blended feeds. For those seeking herbal solutions, Extra-Health, Qilimix, and Recoccider are names associated with its herbal medicinal additives, which are incorporated directly into feed products. Moreover, Tanke Biosciences manufactures and distributes a wide array of trace mineral premix products for livestock and poultry, also under the Qilimix label. Its Tankeball brand extends to natural sweeteners and attractants, specifically formulated for pigs, piglets, fish, and other aquatic animals. Another key product is a water-soluble organic multi-vitamin electrolyte, intended to be dissolved in drinking water for easy animal consumption. The company caters to a broad customer base, encompassing medium to large-scale feed production factories, major livestock operations, and individual farmers. Its products are primarily distributed and sold across the People's Republic of China, Southeast Asia, and Latin America. Tanke Biosciences Corporation was founded in 1989 and maintains its headquarters in Guangzhou, People's Republic of China.